A randomized trial to evaluate the impact of breast density notification on anxiety, breast cancer worry, and perceived risk among Latinas at a federally qualified health center
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Laws mandating that women be informed of mammographic breast density (MBD) with their mammogram results may increase anxiety. We report on changes in self-reported levels of anxiety, worry about developing breast cancer (BC), as well as perceived risk of BC resulting from three MBD notification methods: usual care (mailed notification letter), enhanced care (usual care with MBD educational brochure), or interpersonal care (enhanced care with promotora education), among a Latina population. METHODS: A randomized controlled clinical trial of three MBD notifications was performed among Latina women aged 40 to 74 years receiving screening mammography at a federally qualified health center (FQHC). Measures of anxiety, BC worry and perceived lifetime BC risk were assessed using a questionnaire. Anxiety was measured using the State-Trait Anxiety Inventory scale (STAI-S). The question: "How frequently do you worry about getting breast cancer someday" assessed BC worry. perceived lifetime risk of BC was rated between 0% (no chance) to 100% (definitely will get). Additional surveys were completed at two weeks to six months (T1) and one year (T2) after the intervention. RESULTS: 1332 Latina women were randomized between October 2016 and October 2019. At T0, 51.8% had moderate or severe anxiety. BC worry was reported to be sometimes/ often/ almost all the time among 41.3% of participants. 25.4% reported a perceived lifetime risk of developing BC of > 10%, compared with 6.6% with Gail model estimated lifetime risk score of > 10%. There was no significant difference in the proportion of patients who maintained low or had decrease in their levels of anxiety, BC worry or perceived risk from T0 to either T1 or T2 surveys between intervention groups. CONCLUSION: This Latina cohort had high levels of anxiety and BC worry which persisted regardless of intervention received. Future work is needed to improve our understanding of factors that could lower anxiety and BC worry and improve BC risk perception in this population. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02910986. Registered on 22/09/2016.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- A randomized trial to evaluate the impact of breast density notification on anxiety, breast cancer worry, and perceived risk among Latinas at a federally qualified health center
- Date Crossref
- 02/06/2025
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Mayo Clinic General Internal Medicine pays non établi dans la noticeÉtablissement de santé
-
WinnMed pays non établi dans la noticeOrganisation à but non lucratif
-
Mayo Clinic in Florida pays non établi dans la noticeÉtablissement de santé
-
Mayo Clinic in Arizona pays non établi dans la noticeÉtablissement de santé
-
Mayo Clinic Hospital pays non établi dans la noticeÉtablissement de santé
-
Yale University Department of Internal Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Mountain Park Health Center Department of Integrated Nutrition Services and Collaborative Research pays non établi dans la noticeÉtablissement de santé
-
Division of Clinical Trials and Biostatistics pays non établi dans la noticeÉtablissement de santé
General Internal Medicine — Mayo Clinic, WinnMed et Mayo Clinic in Florida, avec 5 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.